| Dauer bis zur Implantation |
4.00 (2.75, 7.00) |
4.00 (2.00, 6.00) |
0.4 |
| Implantierter Klappentyp |
|
|
0.3 |
| Keine |
0 (0%) |
0 (0%) |
|
| Evolut R |
16 (52%) |
37 (64%) |
|
| Evolut Pro |
6 (19%) |
12 (21%) |
|
| Sapien 3 |
9 (29%) |
9 (16%) |
|
| Selbstexpandierende Klappe |
|
|
0.13 |
| Nein |
9 (29%) |
9 (16%) |
|
| Ja |
22 (71%) |
49 (84%) |
|
| Vordilatation ja/nein |
22 (71%) |
42 (72%) |
0.9 |
| Nachdilatation ja/nein |
5 (16%) |
12 (21%) |
0.6 |
| Valve-in-Valve Operation |
|
|
>0.9 |
| Nein |
30 (97%) |
57 (98%) |
|
| Ja |
1 (3.2%) |
1 (1.7%) |
|
| Anästhesieverfahren |
|
|
0.051 |
| Lokalanästhäsie |
1 (3.2%) |
11 (19%) |
|
| Intubation |
30 (97%) |
47 (81%) |
|
| Länge der Narkosedaten (Sek) |
6,557 (5,858, 8,047) |
6,022 (5,215, 6,870) |
0.022 |
| Kontrastmittelgabe Volumen während der TAVI in ml |
116 (94, 151) |
108 (86, 147) |
0.5 |
| Anzahl der RVP Episoden |
|
|
0.7 |
| 1 |
2 (6.3%) |
9 (16%) |
|
| 2 |
9 (28%) |
17 (29%) |
|
| 3 |
9 (28%) |
16 (28%) |
|
| 4 |
6 (19%) |
8 (14%) |
|
| 5 |
3 (9.4%) |
6 (10%) |
|
| 6 |
2 (6.3%) |
2 (3.4%) |
|
| 7 |
1 (3.1%) |
0 (0%) |
|
| Summierte Zeit von allen Episoden RVP |
61 (39, 79) |
46 (32, 65) |
0.051 |
| Delta_NSE_ng_ml |
0.23 (-0.02, 0.87) |
0.39 (0.06, 1.18) |
0.4 |
| Hepcidin_post |
235 (89, 904) |
428 (248, 808) |
0.13 |
| Neuer Schrittmacher nach TAVI |
|
|
>0.9 |
| Nein |
29 (91%) |
53 (91%) |
|
| Ja |
3 (9.4%) |
5 (8.6%) |
|
| Postoperativer Schlaganfall |
|
|
>0.9 |
| Nein |
31 (97%) |
57 (98%) |
|
| Ja |
1 (3.1%) |
1 (1.7%) |
|
| Bluprodukte_während_KH_Aufnethalt |
2 (6.5%) |
3 (5.2%) |
>0.9 |
| AKI_overall |
11 (34%) |
8 (14%) |
0.022 |
| Renale Komplikation: Dialyse |
1 (3.3%) |
0 (0%) |
0.3 |
| Intraoperativer Perikard-Erguss (nur bei hämodynamischer Relevanz) |
|
|
0.4 |
| Nein |
31 (97%) |
58 (100%) |
|
| Ja |
1 (3.1%) |
0 (0%) |
|
| Bei der Operation verstorben |
|
|
>0.9 |
| Nein |
32 (100%) |
58 (100%) |
|
| Ja |
0 (0%) |
0 (0%) |
|
| ITS_Aufenthalt |
|
|
0.3 |
| Nein |
23 (96%) |
47 (100%) |
|
| Ja |
1 (4.2%) |
0 (0%) |
|
| Im Krankenhaus verstorben |
|
|
>0.9 |
| Nein |
32 (100%) |
58 (100%) |
|
| Ja |
0 (0%) |
0 (0%) |
|
| Hospitalisierungsdauer |
11.5 (8.0, 16.0) |
9.5 (8.0, 12.0) |
0.024 |
| Entlassung nach Hause |
|
|
>0.9 |
| Nein |
3 (9.4%) |
6 (10%) |
|
| Ja |
29 (91%) |
52 (90%) |
|
| Monat_3_Verstorben |
0 (0%) |
1 (1.8%) |
>0.9 |
| Rehospitalisierung |
9 (33%) |
7 (16%) |
0.10 |
| Entlassung in Rehabilitation |
|
|
0.3 |
| Nein |
30 (94%) |
57 (98%) |
|
| Ja |
2 (6.3%) |
1 (1.7%) |
|
| Entlassung in eine Pflegeeinrichtung bzw. in ein Heim |
|
|
>0.9 |
| Nein |
32 (100%) |
58 (100%) |
|
| Ja |
0 (0%) |
0 (0%) |
|
| Verlegung in ein externes Krankenhaus |
|
|
0.4 |
| Nein |
31 (97%) |
53 (91%) |
|
| Ja |
1 (3.1%) |
5 (8.6%) |
|